Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain
Melemedjian, Asiedu, Tillu, Sanoja Raul, Yan Jin, Lark Arianna, Khoutorsky Arkady, Johnson Jessica, Peebles, Lepow Talya, Sonenberg Nahum, Dussor Gregory, Price